Tweets by IDWeek 2023

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

284 Views

047. COVID-19: Treatment: Thursday, 12:15 - 1:30 p.m.

Poster Session: COVID-19: Treatment

(519) Early Transition to Outpatient Remdesivir Increases Patient Satisfaction while Decreasing Hospital Costs

Thursday, October 12, 2023

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Presenting Author(s)

Supavit Chesdachai, MD (he/him/his)

Assistant Professor of Medicine
Mayo Clinic
Rochester, Minnesota, United States

Christina G. Rivera (O'Connor), Pharm.D

pharmacist
Mayo Clinic
Rochester, Minnesota, United States
JR

Jordan K. Rosedahl, n/a

Mayo Clinic
Rochester, Minnesota, United States
LP

Lindsey Philpot, PhD, MPH

Director of Analytics & Quality
Mayo Clinic
Rochester, MN, United States
RD

Ruchita Dholakia, M.S., M.B.A.

Principal Health Services Analyst
Mayo Clinic
Rochester, Minnesota, United States
BB

Bijan J. Borah, Ph.D.

Mayo Clinic
Rochester, Minnesota, United States
ED

Evan Draper, PharmD

Mayo Clinic
Rochester, Minnesota, United States
RA

Richard Arndt, Pharm.D.

Mayo Clinic
Rochester, Minnesota, United States
RG

Ravindra Ganesh, M.B.B.S., M.D.

Mayo Clinic
Rochester, Minnesota, United States
JL

Jennifer J. Larsen, M.S.N., R.N.

Nurse Manager
Mayo Clinic
Rochester, Minnesota, United States
MD

Molly J. Destro Borgen, M.A.

Operations Administrator
Mayo Clinic
Rochester, Minnesota, United States
Raymund R. Razonable, MD

Professor of Medicine
Mayo Clinic
Rochester, Minnesota, United States